Over the last forty years, we have seen the emergence of large cohorts of human samples from research and national healthcare initiatives. Many countries in Europe now have nascent personalised medicine programmes meaning that human genomics is undergoing a step change from being a predominantly research-driven activity to one funded through healthcare. This is evidenced by the recent Declaration of 19 European countries to sequence and share transnationally at least 1M human genomes by 2022. This initiative will catalyse the transition of genomics from the bench to bedside in Europe.

This study aims to coordinate the provision and operation of a standards-compliant container orchestration platform. This will allow execution of containerised software tools and workflow workloads supporting public and sensitive data across ELIXIR Nodes. The study will enable containers to be deployed and operated at scale and across cloud systems through the container orchestration platform in standardised formats which will:

This study aims to coordinate technical, operational and funding aspects of cloud, data and compute services across Europe for the ELIXIR and larger Life Science community within a seamless hybrid cloud ecosystem. It will implement a hybrid cloud ecosystem interoperable with key resources that is accessible to researchers spanning:

The goal of this study is to host and provide standardised compute access to important public reference and sensitive data sets in relevant (cloud) providers such that:

This study aims to develop, refine and deploy ELIXIR-wide Identity and access management through the ELIXIR AAI Service that will underpin the LifeScience AAI (to be deployed across European research infrastructures and beyond). It will do this by: